Drugs / Omega-3 Lipid Emulsion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07162688 | May 2025 → Mar 2028 expected | acute graft versus host disease | Fujian Medical University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3 Lipid Emulsion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07162688 ↗ |
| Route | Intravenous | “Intravenous Omega-3 lipid emulsion administered at a dose of 2 mL/kg/day” NCT07162688 ↗ |